Conceptrichtlijn colorectaal carcinoom 2013 - Oncoline

82938294829582968297829882998300830183028303830483058306830783088309831083118312831383148315831683178318831983208321832283238324832583268327832883298330833183328333833483358336833783388339834083418342Rullier E, Laurent C, Bretagnol F, Rullier A, Vendrely V, Zerbib F. Sphincter-saving resection for all rectalcarcinomas: the end of the 2-cm distal rule. Ann Surg 2005;241:465-9.Rusthoven KE, Kavanagh BD, Cardenes H, et al. Multi-institutional phase I/II trial of stereotactic body radiationtherapy for liver metastases. J Clin Oncol 2009 Apr 1;27(10):1572-8.Ryan R, Gibbons D, Hyland JMP, Treanor D, White A, Mulcahy HE, et al. Pathological response following longcourseneoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 2005;47:141-46.Rydzewski B, Dehdashti F, Gordon BA, et al. Usefulness of intraoperative sonography for revealing hepaticmetastases from colorectal cancer in patients selected for surgery after undergoing FDG PET. AJR Am JRoentgenol 2002;178:353-358.Sabbagh Ann Surg 2013Safi F, Bittner R, Roscher R, et al, Regional chemotherapy for hepatic metastases of colorectal carcinoma(continuous intraarterial versus continuous intraarterial/intravenous therapy). Cancer 1989; 64:379-387.Safi F, Link KH, Beger HG. Is follow-up of colorectal cancer patients worthwhile? Dis Colon Rectum1993;36:636-643.Sagar PM, Pemberton JM. Surgical management of locally recurrent rectal cancer.Br J Surg 1986 Mar;83(3):293-304.Sahay, T.B., Gray, R.E. & Fitch, M. (2000). A qualitative study of patient perspectives on colorectal cancer.Cancer Practice 8, (1), 38-44.Saif MW Secondary hepatic resection as a therapeutic goal in advanced colorectal cancer. World JGastroenterol. 2009 Aug 21;15(31):3855-64.Sakamoto J, Hamada C, Kodaira S, Nakazato H, Ohashi Y.Adjuvant therapy with oral fluoropyrimidines as mainchemotherapeutic agents after curative resection for colorectal cancer: individual patient data meta-analysis ofrandomized trials. Jpn J Clin Oncol. 1999;29(2):78-86.Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ et al. Irinotecan plus fluorouracil andleucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med. 2000;343:905-14.Saltz LB, Clarke S, Díaz-Rubio E, Scheithauer W, Figer A, Wong R, et al. Bevacizumab in combination withoxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase IIIstudy. J Clin Oncol. 2008 Apr 20;26(12):2013-9. doi: 10.1200/JCO.2007.14.9930.Saltz L, Badarinath S, Dakhil S, et al. Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs.FOLFOX-bevacizumab in colorectal cancer. Clin Colorectal Cancer 2012;11:101-11.Sammour T, Zargar-Shoshtari K, Bhat A, Kahokehr A, Hill AG. A programme of Enh N Z Med J. 2010 Jul30;123(1319):61-70.anced Recovery After Surgery (ERAS) is a cost-effective intervention in elective colonicsurgery.Sankararajah D, Forshaw MJ, Aggrawal A, Stewart M, Kirk J. Images of interest. Gastrointestinal: colonicintussusception in adults. J Gastroenterol Hepatol. 2005 Aug;20(8):1300.Richtlijn Colorectaal carcinoom en Colorectale levermetastasen 2013 - CONCEPT 190